We are live on ! Find out more
OPXAW

Opexa Therapeutics, Inc.

Delisted

OPXAW was delisted on the 20th of September, 2017.

5 hedge funds and large institutions have $276K invested in Opexa Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 65 (-1)

38% less capital invested

Capital invested by funds: $446K → $276K (-$170K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
EEG
E.E. Geduld
+$7.31K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$190K
SM
2
Sabby Management
Florida
$46K -$19.8K -162,740 -30%
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$32K
EEG
4
E.E. Geduld
$7K +$7.31K +60,200 New
UBS Group
5
UBS Group
Switzerland
$1K
VKH
6
Virtu KCG Holdings
New York
-$33K -191,436 Closed
TMC
7
Trellus Management Company
Florida
-$2K -12,600 Closed

OPXAW Hedge Fund Activity: Q3 2015 in Review

5 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Opexa Therapeutics, Inc. (OPXAW) for Q3 2015, worth a combined $276K — down 38% from $446K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of OPXAW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest buyer was E.E. Geduld, opening a new position worth an estimated $7.31K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $33K sold.

  • 5 institutional investors held Opexa Therapeutics, Inc. (OPXAW) as of Q3 2015, down from 6 in Q2 2015.
  • Funds reported $276K of Opexa Therapeutics, Inc. stock for Q3 2015, down 38% quarter-over-quarter.
  • 1 fund opened new Opexa Therapeutics, Inc. positions in Q3 2015 and 2 closed out, a net change of -1 holder.
  • The largest Opexa Therapeutics, Inc. buyer in Q3 2015 was E.E. Geduld, an estimated $7.31K added.
  • The largest Opexa Therapeutics, Inc. seller in Q3 2015 was Virtu KCG Holdings, an estimated $33K sold.

Based on aggregated 13F filings for Q3 2015.